<DOC>
	<DOCNO>NCT01051492</DOCNO>
	<brief_summary>Breast cancer common malignancy world-wide , common female malignancy Singapore , rise trend incidence last 2 decade . While improvement treatment , mortality breast cancer remain significant . Development biomarkers predict treatment response toxicity anti-cancer agent rationalize choice therapy individual patient optimize treatment outcome reduce unnecessary toxicity . Development novel therapy novel approach therapy also critical improve treatment armamentarium breast cancer . These research strategy significant impact breast cancer treatment Singapore well globally .</brief_summary>
	<brief_title>Development Predictive Biomarkers Novel Approached Therapy Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>This program recruit mainly cancer patient , predominantly breast cancer patient . The exact inclusion criterion vary individual study . Each individual component study submit DSRB separate approval , along study protocol patient inform consent sheet . The exact exclusion criterion vary individual study . Each individual component study submit DSRB separate approval , along study protocol patient inform consent sheet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>